Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.

Purpose: Recombinant human erythropoietin (rHuEPO) is known to increase thrombotic risk in patients and might have similar effects in athletes abusing the drug. rHuEPO is prohibited by anti-doping legislation, but this risk has not been investigated thoroughly. This analysis was designed to evaluate...

Full description

Bibliographic Details

Published in:	European Journal of Applied Physiology Vol. 120; no. 8; pp. 1893 - 1905
Main Authors:	Heuberger, Jules A. A. C., Posthuma, Jelle J., Ziagkos, Dimitrios, Rotmans, Joris I., Daniels, Johannes M. A., Gal, Pim, Stuurman, Frederik E., Spronk, Henri M. H., Ten Cate, Hugo, Burggraaf, Jacobus, Moerland, Matthijs, Cohen, Adam F.
Format:	research tables/charts randomized controlled trial Journal Article
Published:	Springer Nature Aug2020
Online Access:	View this record in EBSCOhost